<DOC>
	<DOCNO>NCT01277653</DOCNO>
	<brief_summary>There prospective study test interval alpha-fetoprotein ( AFP ) role prothrombin induce vitamin K absence antagonist-II ( PIVKA-II ) surveillance program early detection hepatocellular carcinoma ( HCC ) . The goal study compare test AFP + PIVKA-II interval 3 month effective diagnose early stage HCC 6 month interval AFP commonly use</brief_summary>
	<brief_title>Study PIVKA-II AFP Measurement Surveillance Program Early Detection Hepatocellular Carcinoma</brief_title>
	<detailed_description>There prospective study test interval alpha-fetoprotein ( AFP ) role prothrombin induce vitamin K absence antagonist-II ( PIVKA-II ) surveillance program early detection hepatocellular carcinoma ( HCC ) . The goal study compare test AFP + PIVKA-II interval 3 month effective diagnose early stage HCC 6 month interval AFP commonly use</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>LC previous HCC</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Hepatocellular carcinoma</keyword>
</DOC>